Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May 15;16(3):319-320.
doi: 10.5009/gnl220183.

Waiting for Multi-Stakeholders'Consensus Position Statement on New Nonalcoholic Fatty Liver Disease Nomenclature

Eileen L Yoon  1 , Dae Won Jun  1
Affiliations
Editorial

Waiting for Multi-Stakeholders'Consensus Position Statement on New Nonalcoholic Fatty Liver Disease Nomenclature

Eileen L Yoon et al. Gut Liver. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

Comment on

  • Gut Liver. 16:433.

Similar articles

See all similar articles

Cited by

References

    1. Moon JH, Kim W, Koo BK, Cho NH Innovative Target Exploration of NAFLD (ITEN) consortium, author. Metabolic dysfunction-associated fatty liver disease predicts long-term mortality and cardiovascular disease. Gut Liver. 2022;16:433–442. doi: 10.5009/gnl210167. - DOI - PMC - PubMed
    1. Han E, Lee YH, Lee JS, et al. Fibrotic burden determines cardiovascular risk among subjects with metabolic dysfunction-associated fatty liver disease. Gut Liver. doi: 10.5009/gnl210290. Epub 2022 Mar 24. https://doi.org/10.5009/gnl210290 . - DOI - PMC - PubMed
    1. Kim D, Konyn P, Sandhu KK, Dennis BB, Cheung AC, Ahmed A. Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. J Hepatol. 2021;75:1284–1291. doi: 10.1016/j.jhep.2021.07.035. - DOI - PubMed
    1. Park H, Yoon EL, Kim M, et al. Fibrosis burden of missed and added populations according to the new definition of metabolic dysfunction-associated fatty liver. J Clin Med. 2021;10:4625. doi: 10.3390/jcm10194625.a4dbcdef6bcc4f47ba9259e021eb4f8b - DOI - PMC - PubMed
    1. Lee YB, Moon H, Lee JH, et al. Association of metabolic risk factors with risks of cancer and all-cause mortality in patients with chronic hepatitis B. Hepatology. 2021;73:2266–2277. doi: 10.1002/hep.31612. - DOI - PubMed

Publication types